Pfizer Invites Public to View and Listen to Webcast of June 6 Pfizer Analyst and Investor Meeting at ASCO

NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. invites investors and the general public to view and listen to a webcast of a presentation by Pfizer’s oncology leadership team at an analyst and investor meeting on Monday, June 6, 2011 at 6:00 p.m. Central Daylight Saving Time, in connection with the annual meeting of the American Society of Clinical Oncology (ASCO).

To view and listen to the webcast, visit our web site at www.pfizer.com and click on the “Pfizer Analyst and Investor Meeting at ASCO” link in the Investor Presentations section located on the lower right-hand corner of that page. Information on accessing and pre-registering for the webcast will be available at www.pfizer.com beginning today.

Visitors will be able to view and listen to an archived copy of the webcast at www.pfizer.com.



CONTACT:

Pfizer Inc.
Media:
Chris Loder, 212-733-7897
347-453-8199 (cell)
or
Investor:
Jennifer Davis, 212-733-0717

KEYWORDS:   United States  North America  New York

INDUSTRY KEYWORDS:   Health  Biotechnology  Oncology  Pharmaceutical

MEDIA:

Logo
 Logo

Suggested Articles

Across its 15-year history, Omega Funds has a hand in a clutch of high-profile biotechs such as Editas Medicine and Juno Therapeutics.

After Novartis’ near $10 billion buyout of The Medicines Company, many thought cardiovascular therapies were hot again.

Mutations in RIPK1 can cause uncontrolled cell death and inflammation, researchers discovered by studying families with an autoimmune disorder.